Inventor
ZHANG ZAIJUN
CN13 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG ZAIJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD
6 patentsUS11161800B2Nov 2, 2021
Amantadine nitrate compounds for use as medicaments for the treatment of diseases
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD0 citations59
US11903923B2Feb 20, 2024
Use of andrographolide derivatives in preparation of medicaments for preventing and treating inflammatory bowel diseases
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD0 citations58
US10703729B2Jul 7, 2020
Pyrazine derivative, and preparation method and medical use thereof
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD0 citations48
US10214478B2Feb 26, 2019
Amantadine nitrate compounds with neural protective effect, and preparation and medical use thereof
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD0 citations48
US10308616B2Jun 4, 2019
Trifluoroacetyl hydrazide compounds and methods of preparation and uses thereof
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD0 citations46
US10703730B2Jul 7, 2020
Trifluoroacetyl hydrazide compounds and medical uses thereof
GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD0 citations36
UNIV MACAU
3 patentsUS10011555B2Jul 3, 2018
Methods of treating Parkinson's disease
UNIV MACAU0 citations48
US9475749B2Oct 25, 2016
Anti-neurodegenerative natural compound isolated from alpiniae oxyphyllae fructose and their total synthesis
UNIV MACAU1 citations48
US9486440B2Nov 8, 2016
Uses of indole-ketones or indolidones as neuro-protective drugs
UNIV MACAU0 citations45
QINGDAO HAILAN PHARMACEUTICALS CO LTD
2 patentsUS11197855B2Dec 14, 2021
Use of ligustrazine nitrone derivatives in prevention and treatment of diabetic complication diseases
QINGDAO HAILAN PHARMACEUTICALS CO LTD2 citations64
US12377095B2Aug 5, 2025
Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases
QINGDAO HAILAN PHARMACEUTICALS CO LTD0 citations53